HOTH vs RUN · rev $1.24B vs P/E 6.0, rev $2.04B
Hoth Therapeutics Inc (HOTH) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.
Hoth Therapeutics Inc (HOTH) is a biotechnology company listed on US.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Latest reported HOTH revenue for 2024-03-31 was $1.24B. Net income was -$2.1M. HOTH currently screens at market cap $15.5M.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
HOTH currently screens at market cap $15.5M. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Not investment advice. Open the HOTH and RUN stock pages for the full models.
Not investment advice.